Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025
Omnicell (Nasdaq: OMCL), a leader in pharmacy and nursing care delivery model transformation, has scheduled the release of its first quarter 2025 financial results before market open on Tuesday, May 6, 2025.
The company will host a conference call and webcast to discuss the results at 8:30 a.m. ET on the same day. Interested parties can join via phone using the numbers (800) 715-9871 (U.S.) or (646) 307-1963 (international) with Conference ID 7437144. The presentation will also be accessible through a live and archived webcast on Omnicell's Investor Relations website.
Omnicell (Nasdaq: OMCL), leader nella trasformazione dei modelli di erogazione dei servizi farmaceutici e di assistenza infermieristica, ha programmato la pubblicazione dei suoi risultati finanziari del primo trimestre 2025 prima dell'apertura dei mercati, il martedì 6 maggio 2025.
L'azienda terrà una conference call e una webcast per discutere i risultati alle 8:30 a.m. ET dello stesso giorno. Gli interessati potranno partecipare telefonicamente utilizzando i numeri (800) 715-9871 (USA) o (646) 307-1963 (internazionale) con ID conferenza 7437144. La presentazione sarà inoltre disponibile tramite webcast in diretta e registrata sul sito delle Relazioni con gli Investitori di Omnicell.
Omnicell (Nasdaq: OMCL), líder en la transformación del modelo de prestación de servicios farmacéuticos y de enfermería, ha programado la publicación de sus resultados financieros del primer trimestre de 2025 antes de la apertura del mercado el martes 6 de mayo de 2025.
La compañía realizará una llamada conferencia y una transmisión en vivo para discutir los resultados a las 8:30 a.m. ET ese mismo día. Los interesados pueden unirse por teléfono utilizando los números (800) 715-9871 (EE. UU.) o (646) 307-1963 (internacional) con ID de conferencia 7437144. La presentación también estará disponible a través de una transmisión en vivo y archivada en el sitio web de Relaciones con Inversionistas de Omnicell.
Omnicell (나스닥: OMCL)은 약국 및 간호 서비스 제공 모델 혁신의 선두주자로서, 2025년 1분기 재무 결과를 2025년 5월 6일 화요일 시장 개장 전 공개할 예정입니다.
회사는 같은 날 동부 표준시 오전 8시 30분에 결과를 논의하기 위한 컨퍼런스 콜과 웹캐스트를 진행합니다. 관심 있는 분들은 미국 내 전화번호 (800) 715-9871 또는 국제 전화번호 (646) 307-1963를 통해 회의 ID 7437144로 참여할 수 있습니다. 발표 자료는 Omnicell 투자자 관계 웹사이트에서 실시간 및 녹화된 웹캐스트로도 제공됩니다.
Omnicell (Nasdaq : OMCL), leader dans la transformation des modèles de prestation des soins pharmaceutiques et infirmiers, a prévu la publication de ses résultats financiers du premier trimestre 2025 avant l'ouverture des marchés le mardi 6 mai 2025.
L'entreprise organisera une conférence téléphonique et une webdiffusion pour discuter des résultats à 8h30 ET le même jour. Les personnes intéressées peuvent participer par téléphone en composant les numéros (800) 715-9871 (États-Unis) ou (646) 307-1963 (international) avec l'ID de conférence 7437144. La présentation sera également accessible via une webdiffusion en direct et en replay sur le site des relations investisseurs d'Omnicell.
Omnicell (Nasdaq: OMCL), ein führendes Unternehmen in der Transformation von Apotheken- und Pflegeversorgungsmodellen, hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2025 vor Markteröffnung am Dienstag, den 6. Mai 2025 geplant.
Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast zur Besprechung der Ergebnisse abhalten. Interessierte können telefonisch über die Nummern (800) 715-9871 (USA) oder (646) 307-1963 (international) mit der Konferenz-ID 7437144 teilnehmen. Die Präsentation wird außerdem live und als Aufzeichnung auf der Investor-Relations-Website von Omnicell verfügbar sein.
- None.
- None.
All interested parties are invited to listen to the live call and presentation by dialing (800) 715-9871 in the
About Omnicell
Since 1992, Omnicell has been committed to transforming pharmacy and nursing care through outcomes-centric solutions designed to deliver clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics and smart devices, intelligent software workflows, and data and analytics, all optimized by expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
OMCL-E
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414132966/en/
Kathleen Nemeth
Senior Vice President, Investor Relations
ir@omnicell.com
Source: Omnicell, Inc.
FAQ
When will Omnicell (OMCL) release its Q1 2025 earnings?
How can investors join Omnicell's (OMCL) Q1 2025 earnings call?
What time is Omnicell's (OMCL) Q1 2025 earnings conference call?
Where can I find Omnicell's (OMCL) Q1 2025 earnings webcast?
